Suchergebnisse - "Bile Duct Neoplasms* / blood"

  1. 1

    A Circular RNA, Cholangiocarcinoma‐Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers von Xu, Yi, Leng, Kaiming, Yao, Yue, Kang, Pengcheng, Liao, Guanqun, Han, Yi, Shi, Guangjun, Ji, Daolin, Huang, Peng, Zheng, Wangyang, Li, Zhenglong, Li, Jinglin, Huang, Lining, Yu, Liang, Zhou, Yongxu, Jiang, Xingming, Wang, Hao, Li, Chunlong, Su, Zhilei, Tai, Sheng, Zhong, Xiangyu, Wang, Zhidong, Cui, Yunfu

    ISSN: 0270-9139, 1527-3350, 1527-3350
    Veröffentlicht: United States Wolters Kluwer Health, Inc 01.04.2021
    Veröffentlicht in Hepatology (Baltimore, Md.) (01.04.2021)
    “… Background and Aims Circular RNAs (circRNAs) and extracellular vesicles (EVs) are involved in various malignancies. We aimed to clarify the functions and …”
    Volltext
    Journal Article
  2. 2

    Combined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma von Mizuno, Takashi, Ebata, Tomoki, Yokoyama, Yukihiro, Igami, Tsuyoshi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Kamei, Yuzuru, Nagino, Masato

    ISSN: 1528-1140, 1528-1140
    Veröffentlicht: United States 01.02.2022
    Veröffentlicht in Annals of surgery (01.02.2022)
    “… To evaluate the efficacy and safety of combined vascular resection (VR) in advanced perihilar cholangiocarcinoma (PHC). Hepatectomy combined with portal vein …”
    Weitere Angaben
    Journal Article
  3. 3

    YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors von Marti, Patricia, Stein, Claudia, Blumer, Tanja, Abraham, Yann, Dill, Michael T., Pikiolek, Monika, Orsini, Vanessa, Jurisic, Giorgia, Megel, Philippe, Makowska, Zuzanna, Agarinis, Claudia, Tornillo, Luigi, Bouwmeester, Tewis, Ruffner, Heinz, Bauer, Andreas, Parker, Christian N., Schmelzle, Tobias, Terracciano, Luigi M., Heim, Markus H., Tchorz, Jan S.

    ISSN: 0270-9139, 1527-3350, 1527-3350
    Veröffentlicht: United States Wolters Kluwer Health, Inc 01.11.2015
    Veröffentlicht in Hepatology (Baltimore, Md.) (01.11.2015)
    “… The Yes‐associated protein (YAP)/Hippo pathway has been implicated in tissue development, regeneration, and tumorigenesis. However, its role in …”
    Volltext
    Journal Article
  4. 4

    Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas von Zill, Oliver A, Greene, Claire, Sebisanovic, Dragan, Siew, Lai Mun, Leng, Jim, Vu, Mary, Hendifar, Andrew E, Wang, Zhen, Atreya, Chloe E, Kelley, Robin K, Van Loon, Katherine, Ko, Andrew H, Tempero, Margaret A, Bivona, Trever G, Munster, Pamela N, Talasaz, AmirAli, Collisson, Eric A

    ISSN: 2159-8290, 2159-8290
    Veröffentlicht: United States 01.10.2015
    Veröffentlicht in Cancer discovery (01.10.2015)
    “… Patients with pancreatic and biliary carcinomas lack personalized treatment options, in part because biopsies are often inadequate for molecular …”
    Weitere Angaben
    Journal Article
  5. 5

    Cytologic characteristics of circulating epithelioid cells in pancreatic disease von Rosenbaum, Matthew W., Cauley, Christy E., Kulemann, Birte, Liss, Andrew S., Castillo, Carlos Fernandez‐del, Warshaw, Andrew L., Lillemoe, Keith D., Thayer, Sarah P., Pitman, Martha B.

    ISSN: 1934-662X, 0008-543X, 1934-6638, 1097-0142
    Veröffentlicht: United States Wiley Subscription Services, Inc 01.05.2017
    Veröffentlicht in Cancer (01.05.2017)
    “… BACKGROUND Circulating epithelioid cells (CECs), also known as circulating tumor, circulating cancer, circulating epithelial, or circulating nonhematologic …”
    Volltext
    Journal Article
  6. 6

    Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information von Ettrich, T. J., Schwerdel, D., Dolnik, A., Beuter, F., Blätte, T. J., Schmidt, S. A., Stanescu-Siegmund, N., Steinacker, J., Marienfeld, R., Kleger, A., Bullinger, L., Seufferlein, T., Berger, A. W.

    ISSN: 2045-2322, 2045-2322
    Veröffentlicht: London Nature Publishing Group UK 13.09.2019
    Veröffentlicht in Scientific reports (13.09.2019)
    “… Diagnosis of Cholangiocarcinoma (CCA) is difficult, thus a noninvasive approach towards (i) assessing and (ii) monitoring the tumor-specific mutational profile …”
    Volltext
    Journal Article
  7. 7
  8. 8

    Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma von Yoo, Changhoon, Jeong, Hyehyun, Jeong, Jae Ho, Kim, Kyu-pyo, Lee, Seonmin, Ryoo, Baek-Yeol, Hwang, Dae Wook, Lee, Jae Hoon, Moon, Deog-Bog, Kim, Ki-Hun, Lee, Sang Soo, Song, Tae Jun, Oh, Dongwook, Lee, Myung Ah, Chon, Hong Jae, Lee, Ji Sung, Laliotis, George, Rivero-Hinojosa, Samuel, Spickard, Erik, Renner, Derrick, Dutta, Punashi, Palsuledesai, Charuta C., Sharma, Shruti, Malhotra, Meenakshi, Jurdi, Adham, Liu, Minetta C.

    ISSN: 0168-8278, 1600-0641, 1600-0641
    Veröffentlicht: Netherlands Elsevier B.V 01.05.2025
    Veröffentlicht in Journal of hepatology (01.05.2025)
    “… Surgery is the only curative therapeutic option for resectable extrahepatic cholangiocarcinoma, but recurrence is common, and prognosis is poor. There is an …”
    Volltext
    Journal Article
  9. 9

    Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy von González-Medina, Alberto, Vila-Casadesús, Maria, Gomez-Rey, Marina, Fabregat-Franco, Carles, Sierra, Alexandre, Tian, Tian V, Castet, Florian, Castillo, Gloria, Matito, Judit, Martinez, Paola, Miquel, Josep M, Nuciforo, Paolo, Pérez-López, Raquel, Macarulla, Teresa, Vivancos, Ana

    ISSN: 1557-3265, 1557-3265
    Veröffentlicht: United States 01.10.2024
    Veröffentlicht in Clinical cancer research (01.10.2024)
    “… FGFR2 fusions occur in 10% to 15% of patients with intrahepatic cholangiocarcinoma (iCCA), potentially benefiting from FGFR inhibitors (FGFRi). We aimed to …”
    Weitere Angaben
    Journal Article
  10. 10
  11. 11

    Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes von Yugawa, Kyohei, Itoh, Shinji, Yoshizumi, Tomoharu, Iseda, Norifumi, Tomiyama, Takahiro, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki

    ISSN: 0893-3952, 1530-0285, 1530-0285
    Veröffentlicht: New York Elsevier Inc 01.04.2021
    Veröffentlicht in Modern pathology (01.04.2021)
    “… Tumor microvessel density (MVD) is a prognostic factor for patients with intrahepatic cholangiocarcinoma (ICC). Tumor-infiltrating lymphocytes (TILs) are also …”
    Volltext
    Journal Article
  12. 12

    Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma von Yang, Ju Dong, Campion, Michael B., Liu, Minetta C., Chaiteerakij, Roongruedee, Giama, Nasra H., Ahmed Mohammed, Hager, Zhang, Xiaodan, Hu, Chunling, Campion, Victoria L., Jen, Jin, Venkatesh, Sudhakar K., Halling, Kevin C., Kipp, Benjamin R., Roberts, Lewis R.

    ISSN: 0270-9139, 1527-3350
    Veröffentlicht: United States Wolters Kluwer Health, Inc 01.01.2016
    Veröffentlicht in Hepatology (Baltimore, Md.) (01.01.2016)
    “… Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are …”
    Volltext
    Journal Article
  13. 13

    Initial outcomes of a single-institution hepatic artery infusion pump program for colorectal liver metastases and intrahepatic cholangiocarcinoma: Safety, feasibility, and circulating tumor DNA tracking von Ocuin, Lee M., Stitzel, Henry, Chung, Michelle, Tirumani, Sree Harsha, Elshami, Mohamedraed, Tomaro, Maria, Miller-Ocuin, Jennifer L., Deitz, David W., Steinhagen, Emily, Charles, Ronald, Costedio, Meagan, Liu, Michael, Lumish, Melissa, Selfridge, J. Eva

    ISSN: 0039-6060, 1532-7361, 1532-7361
    Veröffentlicht: United States Elsevier Inc 01.06.2025
    Veröffentlicht in Surgery (01.06.2025)
    “… Hepatic artery infusion with floxuridine is a treatment option for patients with colorectal liver metastases or intrahepatic cholangiocarcinoma. Outcomes from …”
    Volltext
    Journal Article
  14. 14

    Prognostic significance of the cachexia index for patients with perihilar cholangiocarcinoma von Sakashita, Katsuya, Otsuka, Shimpei, Ashida, Ryo, Ohgi, Katsuhisa, Kato, Yoshiyasu, Dei, Hideyuki, Notsu, Akifumi, Uesaka, Katsuhiko, Sugiura, Teiichi

    ISSN: 0039-6060, 1532-7361, 1532-7361
    Veröffentlicht: United States Elsevier Inc 01.06.2025
    Veröffentlicht in Surgery (01.06.2025)
    “… The prognostic value of the preoperative cachexia index for patients with perihilar cholangiocarcinoma remains unclear. We retrospectively evaluated 236 …”
    Volltext
    Journal Article
  15. 15

    Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway von Pei, Yao-Fei, Liu, Jie, Cheng, Jian, Wu, Wei-Ding, Liu, Xi-Qiang

    ISSN: 1525-2191, 1525-2191
    Veröffentlicht: United States 01.08.2019
    Veröffentlicht in The American journal of pathology (01.08.2019)
    “… Cholangiocarcinoma (CCA) is a malignant cancer that is associated with high mortality rates. The relationship between laminin γ 2 chain gene (LAMC2) and …”
    Weitere Angaben
    Journal Article
  16. 16

    A New Clinically Based Staging System for Perihilar Cholangiocarcinoma von Chaiteerakij, Roongruedee, Harmsen, William S, Marrero, Carlos Romero, Aboelsoud, Mohammed M., Ndzengue, Albert, Kaiya, Joseph, Therneau, Terry M, Sanchez, William, Gores, Gregory J, Roberts, Lewis R

    ISSN: 0002-9270, 1572-0241, 1572-0241
    Veröffentlicht: United States Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01.12.2014
    Veröffentlicht in The American journal of gastroenterology (01.12.2014)
    “… Current staging systems for perihilar cholangiocarcinoma (pCCA) are inadequate, as they are based on surgical pathology and therefore not relevant to …”
    Volltext
    Journal Article
  17. 17

    Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma von Miki, Atsushi, Sakuma, Yasunaru, Teratani, Takumi, Sasanuma, Hideki, Nishimura, Wataru, Yamaguchi, Hironori

    ISSN: 1791-7530, 1791-7530
    Veröffentlicht: Greece 01.11.2025
    Veröffentlicht in Anticancer research (01.11.2025)
    “… The Albumin-Bilirubin (ALBI) score was initially developed to estimate prognosis in patients with hepatocellular carcinoma. Recently, its prognostic relevance …”
    Weitere Angaben
    Journal Article
  18. 18
  19. 19

    HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium von Xu, Yun-Fei, Liu, Zeng-Li, Pan, Chang, Yang, Xiao-Qing, Ning, Shang-Lei, Liu, Hong-Da, Guo, Sen, Yu, Jin-Ming, Zhang, Zong-Li

    ISSN: 0950-9232, 1476-5594, 1476-5594
    Veröffentlicht: London Nature Publishing Group UK 01.02.2019
    Veröffentlicht in Oncogene (01.02.2019)
    “… Perihilar cholangiocarcinoma (PHCCA) is the most common type of cholangiocarcinoma with low resection rate and high morbidity. The study of PHCCA biomarkers …”
    Volltext
    Journal Article
  20. 20

    Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy von Ha, Hyerim, Nam, Ah-Rong, Bang, Ju-Hee, Park, Ji-Eun, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn

    ISSN: 1949-2553
    Veröffentlicht: United States 22.11.2016
    Veröffentlicht in Oncotarget (22.11.2016)
    “… Programmed death-ligand 1 (PD-L1) expression in tumor tissue is under investigation as a candidate biomarker in immuno-oncology dug development. The soluble …”
    Weitere Angaben
    Journal Article